Healthy males and females
Conditions
Interventions
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy males and females from 20 to 64 years old (2) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
Exclusion criteria
Exclusion criteria: (1) Subjects with a history of mental illness, diabetes, liver diseases, renal disease, gastrointestinal disease, cardiac disease, respiratory disease, peripheral vascular disease, or other serious disease (2) Subjects who have undergone gastrointestinal surgery (3) Subjects with abnormal liver or kidney function tests (4) Subjects with currently treated medical conditions (5) Subjects who are allergic to food and drugs (6) Subjects with anemia symptoms (7) Female participants wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female participants (8) Subjects who play intense sports and subjects who are on a diet (9) Subjects with extremely irregular lifestyles (10) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (11) Subjects who are continuously receiving treatment with pharmaceuticals (including OTC and prescription drugs) (12) Subjects who drink exceed 40 g of average pure daily alcohol (13) Subjects who smoke an average of 21 or more cigarettes a day (14) Subjects who are participating in or will participate in other clinical trials at the start of this study (15) Others, subjects judged by the principal investigator or the co-investigator to be inappropriate for the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood flows in the medial aspect of the elbow (non-dominant side), face, and calves | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed